• The Follow-Up and Utilization of Drug Treatment for Chronic Hbv/Hcv Patients with Major Psychiatric Diseases in Taiwan

    Nov 1, 2016, 00:00

  • The Effect of Acne on The Quality of Life In Bulgaria - Pilot Study

    Nov 1, 2016, 00:00

  • Prediction of the Morbidity with Bacterial Purulent Meningitis of Various Origin with Consideration of the Existing Vaccine Prevention Procedures

    Nov 1, 2016, 00:00

  • Development of a Mapping Algorithm Between the SGRQ and EQ-5D-5L Utility Values in a Severe Asthma Population

    Nov 1, 2016, 00:00

  • Cost Of Total Parenteral Nutrition Services At Ministery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • High Prevalence But Poor Awareness And Knowledge of Atrial Fibrillation Among The Elderly In Hong Kong

    Nov 1, 2016, 00:00

  • The Burden of Depression in Japan

    Nov 1, 2016, 00:00

  • The Use Of Administrative Data To Determine Prevalence And Incidence Of Copd- A Systematic Review

    Nov 1, 2016, 00:00

  • Variation in the Number and Type of Heart Valve Procedures Performed in the UK – Is Patient Access Equitable?

    Nov 1, 2016, 00:00

  • The Humanistic and Economic Burden of Irritable Bowel Syndrome with Diarrhoea (IBS-D) by Disease Severity among Patients in The EU5 Region

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • Network Meta-Analysis Comparing Palbociclib with Chemotherapies For Treatment of Postmenopausal Women With HR+/ HER2- Advanced/ Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease Patients

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Brca Mutation Testing for Early-Stage Breast Cancer Patients with Family History in Malaysia

    Nov 1, 2016, 00:00

  • Gout Diagnosis and Possible Increased Risk of Joint Replacement- A Population-Based Cohort Study of Older Adults

    Nov 1, 2016, 00:00

  • Early Market Access for Pharmaceuticals in EU- What is the Impact of Ema’s Accelerated Assessment Procedure?

    Nov 1, 2016, 00:00

  • Impact Of Changes In The Methodology Of External Price Referencing On Prices

    Nov 1, 2016, 00:00

  • Utilities Associated with The Number of Days on Parenteral Support in The Treatment of Short Bowel Syndrome

    Nov 1, 2016, 00:00

  • Experience Seeking Appropriate Standards of Cost-Effectiveness Ratio- Updates and Challenges in Japanese Setting

    Nov 1, 2016, 00:00

  • Healthcare Expenditures and Equity in Healthcare Utilization for Lymphedema Patients in France

    Nov 1, 2016, 00:00

  • How To Ensure An Efficient Resource Allocation For The Treatment of Chronic Myeloid Leukemia

    Nov 1, 2016, 00:00

  • Assessment of Prescribing Indicators in Public and Private Primary Health Care Facilities in Indonesia

    Nov 1, 2016, 00:00

  • Biosimilars- Market Access and Market Penetration – A Comparison of France and Germany

    Nov 1, 2016, 00:00

  • Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems

    Nov 1, 2016, 00:00

  • Evaluating Patient Access to Targeted Therapeutics Amidst the Evolving Singaporean Health Care Landscape

    Nov 1, 2016, 00:00

  • Cost-Effective Analysis Of The Dengue Vaccine In Costa Rica

    Nov 1, 2016, 00:00

  • Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197-2013 (±15%)

    Nov 1, 2016, 00:00

  • Rheumatoid Arthritis is Associated with an Increased Risk of Depression in Elderly Patients in Germany

    Nov 1, 2016, 00:00

  • Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context

    Nov 1, 2016, 00:00

  • Estimated Costs of Locoregional and Metastatic Recurrences in Patients with HER2+ Breast Cancer in Spain

    Nov 1, 2016, 00:00

  • Identifying Higher-Value Subpopulations For Treatment In Heterogenous Rare Diseases- An Example Study of Early Responders to Teduglutide for Short Bowel Syndrome

    Nov 1, 2016, 00:00

  • Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)

    Nov 1, 2016, 00:00

  • Use Of Surveillance Databases To Describe Influenza Epidemiology In Europe

    Nov 1, 2016, 00:00

  • The Economic Burden of Hepatitis C In France And Romania

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Depends on the Subsequent Treatment Sequen An Example from Multiple Sclerosis

    Nov 1, 2016, 00:00

  • A Review Of Patient-Reported Outcome Measures To Assess Infertility-Related Quality Of Life

    Nov 1, 2016, 00:00

  • Levonorgestrel Intrauterine System And Norethisterone For The Treatment of Chronic Abnormal Uterine Bleeding- A Randomized Clinical Comparison In The Patients of Bahawalpur, Pakistan

    Nov 1, 2016, 00:00

  • Validity of Child Health-6 Dimension(CH-6D) for Adolescents

    Nov 1, 2016, 00:00

  • The Coeliac Disease Assessment Questionnaire (Cdaq)- Development of a Patient-Reported Outcome Measure

    Nov 1, 2016, 00:00

  • Teledermoscopy as a Referral Method in Australia- A Decision Analytic Model

    Nov 1, 2016, 00:00

  • Patience is a Virtue When Connecting Evidence Networks

    Nov 1, 2016, 00:00

  • Clinical And Economic Impact of Treatment-Free Interval In Patients With Relapsed/Refractory Multiple Myeloma

    Nov 1, 2016, 00:00

  • Systematic Literature Review to Assess Prevalence of Gina-Defined Segments of Asthma and Phenotypes

    Nov 1, 2016, 00:00

  • Societal Impact of One-Time Screening for Diabetes at Age 30 in the Indian Population- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Determination of Serum Carbamazepine Concentration Using Dried Blood Spot Specimens for Resource Limited Settings

    Nov 1, 2016, 00:00

  • Using Best-Worst Scaling Choice Experiments to Elicit the Most Important Domains of Health-Related Quality of Life (HRQOL) in Singapore

    Nov 1, 2016, 00:00

  • Quick Assessment on Lung Cancer Screening with Low-Dose Computed Tomography

    Nov 1, 2016, 00:00

  • Data Imputation for Missing Values in a Claim-Based Administrative Database- Comparison of Imputatation Approaches

    Nov 1, 2016, 00:00

  • Social Preferences for Rare Diseases in Spain

    Nov 1, 2016, 00:00

  • A Qualitative Study to Explore The Experiences of Lung Cancer Patients About Disease and its Prevention

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Threshold Proposal For Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • Market Access In The Context Of Economic Crisis- Insights From Several European Countries

    Nov 1, 2016, 00:00

  • A Review Evaluating the Validity of Motion-Based Gaming Platforms to Measure Clinical Outcomes in Clinical Research

    Nov 1, 2016, 00:00

  • A Review of the Cost of Medication Nonadherence in Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Market Access of Innovative Anticancer Drugs in Algeria- Funding Based on Clinical or Economic Evidence?

    Nov 1, 2016, 00:00

  • The Utilization Of Selected Screening Tests In Gree A Descriptive Analysis

    Nov 1, 2016, 00:00

  • Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Screening Program

    Nov 1, 2016, 00:00

  • Effect of Smoking Status on Costs-of-Illness in Patients with a Depressive Disorder in Spain- An Approximation from the National Health Survey

    Nov 1, 2016, 00:00

  • Adherence of Patients with Type 2 Diabetes to Medications – The Role Of Risk Preferences

    Nov 1, 2016, 00:00

  • A Simulation Model for Peripheral Arterial Disease- Methods and Application of A Markov Model

    Nov 1, 2016, 00:00

  • Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in Spain- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Outcomes Prediction Using a Generalized Linear Model in a Cohort of Schizophrenic Patients Receiving Paliperidone Long Acting Injectable Treatment in Hong Kong

    Nov 1, 2016, 00:00

  • Cost of 1st Line Treatment Failure in Braf V600 Mutated Metastatic Melanoma in France

    Nov 1, 2016, 00:00

  • A Qualitative Comparison of German and UK Health Technology Assessments- Vedolizumab Case Study

    Nov 1, 2016, 00:00

  • An International Patient Survey on Health Related Quality of Life Aspects not Cpatured by EQ-5D-5L

    Nov 1, 2016, 00:00

  • Comparison of Mirena Intrauterine Device with Oral Progesterone Treatment and Surgical Treatment in Idiopathic Menorrhagia Patients- Results of A Cost-Minimisation Analysis

    Nov 1, 2016, 00:00

  • Considering or Not Adverse Events in Health Economic Models- A Pragmatic Approach

    Nov 1, 2016, 00:00

  • Pricing and Market Access of Orphan Drugs in China- Analysis of National and Provincial Policy and the Associated Impact on Coverage

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Treatment of Arm Fractures In Elderly Men And Women – A Systematic Review of The Literature

    Nov 1, 2016, 00:00

  • To What Extent Does the Published Economic Analyses of Treatments for Opioid Use Disorder Capture its Chronic, Relapsing Nature and its Impact on Society?

    Nov 1, 2016, 00:00

  • Economic Evaluation of Dengue Vaccination in Bangkok Metropolitan Administration

    Nov 1, 2016, 00:00

  • Treatment Patterns, Biomarker Testing (BMX) Practices and Healthcare Resource Use (HCRU) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in Taiwan

    Nov 1, 2016, 00:00

  • Impact of Obesity on Patient-Reported Outcomes after Total Knee Replacement

    Nov 1, 2016, 00:00

  • Burden of Cancers Attributable to Tobacco Smoking in Member Countries of the Association of South East Asian Nations (Asean), 2012

    Nov 1, 2016, 00:00

  • Is There A Difference In Perception And Practice In Pharmacological Management Of Schizophrenia- A Cross Sectional Survey In India

    Nov 1, 2016, 00:00

  • Health Insurance Cost of Stroke in Hungary- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Cost Of Lost Productivity Due To Premature, Suicide-Related Mortality In Poland

    Nov 1, 2016, 00:00

  • Pediatric Registry Of Patients With Severe Persistent Uncontrolled Asthma Receiving Omalizumab

    Nov 1, 2016, 00:00

  • The Impact of Extrapolating Survival Based on Cure Models- Comparing Mean Incremental Survival and Cure Rates in Different Datasets

    Nov 1, 2016, 00:00

  • A Cost-effectiveness Analysis of Pharmacokinetic (Pk) Driven Prophylaxis VS. Standard Prophylaxis In Haemophilia A

    Nov 1, 2016, 00:00

  • Economic Evaluation of The Portuguese Needle Exchange Programme In Community Pharmacies (NEP-CP)

    Nov 1, 2016, 00:00

  • Applying A Simulation Model to Manage Waiting Lists For Hospital Inpatient Activity in AN EU Region

    Nov 1, 2016, 00:00

  • Spiralling Healthcare Expenditure in Malaysia- Is it Sustainable?

    Nov 1, 2016, 00:00

  • Adverse Events in Relaxing Virtual Environments

    Nov 1, 2016, 00:00

  • Health Insurance Treatment Cost of Colorectal Cancer in Hungary

    Nov 1, 2016, 00:00

  • Effectiveness Of Self-Monitoring Of Blood Glucose (Smbg) In Reducing Hba1c Of Diabetes Mellitus Type-2 Patients In Jakarta, Indonesia- Preliminary Findings

    Nov 1, 2016, 00:00

  • Participation Of External Medical Societies In The Benefit Assessment Of Pharmaceuticals In Germany

    Nov 1, 2016, 00:00

  • Social Return on Investment in Psoriasis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France

    Nov 1, 2016, 00:00

  • Pharmacotherapies for the Treatment of Behavioral and Psychological Symptoms of Dementia - A Systematic Review On Recent Evidence

    Nov 1, 2016, 00:00

  • A Prospective Study of Antihypertensive Drugs Utilization Pattern in Outpatients of a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • HTA On Role of Chitosan In Hemostasis

    Nov 1, 2016, 00:00

  • Comparison of Medical Costs, Health Care Utilization, and Health Outcomes Between the Elderly with and Without Disabilities in Korea

    Nov 1, 2016, 00:00

  • Type 2 Diabetes in Turkey – A Cost of Illness Study

    Nov 1, 2016, 00:00

  • A Propensity Score Matched Study of Plasmablade Vs Coblation Technology During Pediatric Tonsillectomy and Adenoidectomy Procedures

    Nov 1, 2016, 00:00

  • The Shift From A Compassionate Drug Use To The Common Market–Access Process- An Inflationary No Man’s Land?

    Nov 1, 2016, 00:00

  • The Emerging Roles of Pharmacists in Selected Tertiary Hospitals in Pangasinan and La Union- Focus on Pharmaceutical Care and Pharmacovigilance

    Nov 1, 2016, 00:00

  • Network Meta-Analysis Across Longitudinal Time Points- A Comparison of Available Methods

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant

    Nov 1, 2016, 00:00

  • Don't Put Off Until Tomorrow What You Can Do Today- Cost-Effectiveness of Trastuzumab Plus Paclitaxel Combination Therapy and Sequential use of Paclitaxel and Trastuzumab in the Treatment of Metastatic Breast Cancer in Singapore

    Nov 1, 2016, 00:00

  • Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated With Infliximab, Etanercept And Adalimumab In Nordic Setting

    Nov 1, 2016, 00:00

  • Multithreading- Turbocharged Cost-Effectiveness Analyses in Microsoft Excel

    Nov 1, 2016, 00:00

  • Analysis of Affordability and Consumption of Statins in Ukraine in 2015

    Nov 1, 2016, 00:00

  • COPD Drugs In Europe - A Comparison of Market Access Decisions In France, Germany, Sweden and UK with The Prismaccess Database

    Nov 1, 2016, 00:00

  • How Gifts and Brand Reminders Influence the Generic Brand Selection Among Physicians?

    Nov 1, 2016, 00:00

  • ORphan Drug Market Analysis In Turkey

    Nov 1, 2016, 00:00

  • assessment Of Willingness To Pay For Consultaion And Diagnostic Services In Sheikh Khalifa Bin Zayyed Al-Nayyan Medical Complex, Quetta

    Nov 1, 2016, 00:00

  • Institute for Clinical and Economic Review (ICER) VS. Health Technology Assessment (HTA) Agencies- The Case of Multiple Myeloma and PCSK9S

    Nov 1, 2016, 00:00

  • Invisible Lever for Access to Innovative Therapies in Bulgaria

    Nov 1, 2016, 00:00

  • Oral And General Health Related Quality of Life In Times of Crisis In Greece

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of National Cervical Cancer Screening Program in Denmark- Cytology with HPV triage vs. HPV Primary Screening with Reflex Cytology Triage Cintec Plus Cytology

    Nov 1, 2016, 00:00

  • Price And Utilization Of New Drugs Under A Single Public Payer System- Evidence From Taiwan

    Nov 1, 2016, 00:00

  • The Burden of Selected Cancers in The United States- Health Behaviors and Healthcare Utilization of Survivors

    Nov 1, 2016, 00:00

  • Value Added Medicines- What Value Repurposed Medicines Might Bring To Society?

    Nov 1, 2016, 00:00

  • A Systematic Review Of The Cost-Effectiveness Of Quadrivalent Influenza Vaccine

    Nov 1, 2016, 00:00

  • Comparative Exploratory Analysis on Effectiveness, Tolerability And Patient/Nurse Satisfaction With Two Non-Invasive Patient Controlled Analgesia Treatments For Acute Post-Operative Pain Management

    Nov 1, 2016, 00:00

  • Has Access To Innovative Therapies In Poland Improved Following The 2012 Reimbursement Act?

    Nov 1, 2016, 00:00

  • Burden of Medically Attended Acute Gastroenteritis in England- A Cohort Study in CPRD

    Nov 1, 2016, 00:00

  • Epidemiological Profiling of Chronic Headache Patients At A Public Tertiary Care Setting in India

    Nov 1, 2016, 00:00

  • Hospital Resource Utlization of Patients Over 40 Years old with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2016, 00:00

  • The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany

    Nov 1, 2016, 00:00

  • Indicators in Evaluating Financial and Economic Performance of Pharmacy- A Systematic Review

    Nov 1, 2016, 00:00

  • Health Technology Assessment (HTA) for Orphan Drugs in Cost-Effectiveness (CE) Markets- Current Development and Future Trends

    Nov 1, 2016, 00:00

  • Cost Study of Respiratory System Diseases

    Nov 1, 2016, 00:00

  • Global Evaluation of European Submission Template to Inform HTA and Payer Submissions

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns and Outcomes for Patients with Advanced Soft Tissue Sarcoma Receiving Systemic Therapy in The United Kingdom

    Nov 1, 2016, 00:00

  • Study On Medication Adherence Behavior And Quality Of Life In Elderly Diabetc, Hypertension Patients In A Tertiary Care Hospital; A Prospective Study

    Nov 1, 2016, 00:00

  • Innovative Therapies for The Treatment of Cancer- An Overview of Late-Phase Clinical Development

    Nov 1, 2016, 00:00

  • The Effect of Traditional Medicine on Quality of Life in Patients with Atopic Dermatitis- A Review of Recent Clinical Trials

    Nov 1, 2016, 00:00

  • The Economic Burden of Atrial Fibrillation in Latin America

    Nov 1, 2016, 00:00

  • Evaluating The Economic Impact Of Potentially Inappropriate Prescribing In Older People In Ireland Using A Markov Modelling Approach

    Nov 1, 2016, 00:00

  • The value of timely implementation in hiv/sti testing- cost-effectiveness vs. Speed of intervention rollout

    Nov 1, 2016, 00:00

  • Use of Real World Data in Identifying Relevant Comparators in Medico Economic Models at EU5 Level- A Case Study on Multiple Myeloma

    Nov 1, 2016, 00:00

  • Comparing The Safety Profiles Of Biosimilars With Their Originators’- A Cross Sectional Analysis On The Eu-Rmp

    Nov 1, 2016, 00:00

  • Heart Rate Recovery in Inflammatory Bowel Disease (Ibd)

    Nov 1, 2016, 00:00

  • The Mosaic Study- Regional Variation in Treatment Patterns Associated with Progression from Initial Insulin Regimen

    Nov 1, 2016, 00:00

  • Central Nervous System, Multiple Sclerosis And Social Security- The Economic Burden On The Social Security System Pensions In Italy

    Nov 1, 2016, 00:00

  • Real World Data in Health Technology Assessments –Use of Routinely Collected Data to Address Epidemiologic Questions in Kidney Transplantation in the Amnog Process in Germany

    Nov 1, 2016, 00:00

  • Improving Medication Adherence Through Calendar Packaging- Results of A Randomized Controlled Trial among Hypertensive Patients in Malaysia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of the Pharmacist-Assisted Warfarin Monitoring Program (PAWM) at a Medical Center in Taiwan

    Nov 1, 2016, 00:00

  • Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

    Nov 1, 2016, 00:00

  • Association of Patient-Reported Anxiety and Depression with Clinical Measurements, Disability, and Treatment Satisfaction Among Patients with Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • The Comparative Pharmacoeconomic Analysis of Using Different Reperfusion Strategies for Patients with St Segment Elevation Myocardial Infarction (STEMI)

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Opioid use Disorder Measured by Utilities- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Self-Medication with Antibiotics in Sana'a City

    Nov 1, 2016, 00:00

  • Understanding Continuity of Care at a Provider and Practice Level

    Nov 1, 2016, 00:00

  • Risk of Motor-Vehicle Accidents Increases with Multimorbidity

    Nov 1, 2016, 00:00

  • Choosing First-Line Treatment of Metastatic Colorectal Cancer Based on Biomarker Ras Status- A Budget Impact Analysis From Brazilian Health Insurance System Perspective

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure with Reduced Ejection Fraction- The Use of Model Calibration To Improve Generalisability To A UK CHF Population

    Nov 1, 2016, 00:00

  • Review of Clinical Practice Guidelines and Treatment Patterns in Metastatic Pancreatic Cancer in EU-5 Countries

    Nov 1, 2016, 00:00

  • The Impacts of Case Payment in Rural Hainan of China

    Nov 1, 2016, 00:00

  • Effectiveness Factors In HTA Reports Concerning Type 2 Diabetes

    Nov 1, 2016, 00:00

  • The Coordination Of Care In Pmaq-Ab- An Analysis Based On The Item Response Theory

    Nov 1, 2016, 00:00

  • The Importance of Model Conceptualisation- A Case Study in Ankylosing Spondylitis (AS) and Non-Radiographic Axial Spondyloarthritis (NR-AXSPA)

    Nov 1, 2016, 00:00

  • DRG Appropriateness Analysis Using Activity-Based-Costing Method – A Case of Burn Diagnosis

    Nov 1, 2016, 00:00

  • A Regional Analysis of Relapsing Remitting MS (RRMS) Patients Treated with Natalizumab Suggests a Need to Diagnose and Treat Early in Latin Americans

    Nov 1, 2016, 00:00

  • Substitutability of Dry Powder Inhalers- A Perspective from German Pulmonologists

    Nov 1, 2016, 00:00

  • Economic Burden of Gefitinib Versus Pemetrexed for Insured Patients with Lung Cancer in Urban Xinjiang Province, China- A Real World Research

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Serum Free Light Chain Assay (FREELITE®) for The Diagnosis of Monoclonal Gammopathy in The Brazilian Public and Private Healthcare Systems

    Nov 1, 2016, 00:00

  • Fixed-Dose Combination Drugs Undergoing Amnog - Learnings from 5 Years

    Nov 1, 2016, 00:00

  • The Effectiveness of Pre-Filled Versus Manually Filled Flush Syringes in Intravascular Devices Maintenan A Meta-Analysis

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1a Hcv In Greece

    Nov 1, 2016, 00:00

  • Patient Group Submissions (PGSS) in Health Technology Assessment (HTA) In Scotland- Prevalence And Impact

    Nov 1, 2016, 00:00

  • Toward A New Business Model for Biosimilars

    Nov 1, 2016, 00:00

  • National Survey of Drug Information Centers Practice in Saudi Arabia- Evidence Based Medicine-Therapeutics Guidelines System (Ebm-Tg) At Moh

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene

    Nov 1, 2016, 00:00

  • Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated

    Nov 1, 2016, 00:00

  • The Impact of Age- And Gender- Differences In Direct Hospitalization Costs for Hemorrhagic Stroke In-Patients with Basic Medical Insurance Scheme For Urban Residents of China

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Latin-American (LATAM) Markets- Systematic Evaluation in 5 Latam Countries

    Nov 1, 2016, 00:00

  • Identifying The Unmet Medical Need of Angelman Syndrome- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Interactive Health Economic Models Configured With Google Analytics. Data And Metrics Applicable For A Healthcare Research

    Nov 1, 2016, 00:00

  • A Real World Cost Analysis of Serum Hbsag Quantification Test in Patients with Chronic Hepatitis B- The Case of The University of Naples Federico II

    Nov 1, 2016, 00:00

  • Patient Compliance to Treatment with Gliclazide for Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes In Japanese Oncology Products - Review Of The Pmda Labels

    Nov 1, 2016, 00:00

  • Red and Processed Meat Intake Perception in the Portuguese Population- Association with the WHO Alert of 2015 – Preliminary Results of the Malert Study

    Nov 1, 2016, 00:00

  • Deterministic Vs Microsimulation; A Case Study In Systemic Lupus Erythematosus (SLE)

    Nov 1, 2016, 00:00

  • Treatment of Upper-Extremity Sarcoma with Limb-Salvage Procedures Showed Good Functional Outcomes- A Pilot Study Of 13 Consecutive Patients

    Nov 1, 2016, 00:00

  • Has Pharmaceutical Innovation Increased Persistence and Adherence of Multiple Sclerosis Patients in Germany?

    Nov 1, 2016, 00:00

  • Heterogeneous Preferences For Delaying Onset Of Alzheimer’s Disease Among Older Adults In The Us

    Nov 1, 2016, 00:00

  • Cost of Healthcare Among Metastatic Lung Cancer Patients Receiving Chemotherapy

    Nov 1, 2016, 00:00

  • Use of Health Economic Information in the Management of Health Care Resource Allocation

    Nov 1, 2016, 00:00

  • Clinical And Economic Outcomes Of Patients Hospitalized For Herpes Zoster In Hong Kong

    Nov 1, 2016, 00:00

  • The Potential Public Health Impact of Varicella Vaccination in Hungary

    Nov 1, 2016, 00:00

  • Cost-Utility of Denosumab For The Treatment of Postmenopausal Osteoporosis In Colombia

    Nov 1, 2016, 00:00

  • Systematic Review Of Studies Estimating The Cost-Effectiveness Of Hiv Pre-Exposure Prophylaxis (Prep) In Men Who Have Sex With Men (Msm)

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Locomotor Capabilities Index-5

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra ®) For The Treatment of Ankylosing Spondylitis In Nine European Countries

    Nov 1, 2016, 00:00

  • Health Care Applicability of A Patient-Centric Web Portal For Patients' Medication Experience

    Nov 1, 2016, 00:00

  • Artificial Integligence To Support The Development Of Health Technology Assessment Reports

    Nov 1, 2016, 00:00

  • Renal Anemia Treatment in the Us- How Payer Policies and Physician Preferences Drive Prescribing and How will the Emerging Oral HIF-PH Inhibitors Influence Payers and Physicians?

    Nov 1, 2016, 00:00

  • International Reference Pricing- Measuring Country Influence

    Nov 1, 2016, 00:00

  • Challenges in the Assessment of Medical Devices- Recommendations from the Medtechta Project

    Nov 1, 2016, 00:00

  • Analysis of Two Pressure Ulcer Dressings for Cost Reduction In The Brazilian Public Health System

    Nov 1, 2016, 00:00

  • Widening Engagement with HTA Though open online Learning

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • Real Life Progression Free Survival and Treatment Patterns For Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapies in Fran Analysis of Ims Rwd Oncology Cross-Sectional Survey Data

    Nov 1, 2016, 00:00

  • Local Utilities for Local Studies- Data Availability and Methodology in Japan and Korea

    Nov 1, 2016, 00:00

  • A Review on the Current Status of Health Economic Modeling in Personalized Medicine

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Burns Management in Nigeria- A Case Study of National Orthopaedic Hospital, Enugu

    Nov 1, 2016, 00:00

  • Economic Burden of Varicella In Children In Poland, 2011–2015

    Nov 1, 2016, 00:00

  • What is an Efficient and Affordable Trastuzumab Therapy in a Middle-Income Country? - Adjuvant Therapy with Trastuzumab in Management of Early HER2-Positive Breast Cancer in Iran

    Nov 1, 2016, 00:00

  • Adoption of Innovative Technologies and Substitution Effects- Computed Tomographic Coronary Angiography In Australia

    Nov 1, 2016, 00:00

  • Evaluation Of The Clinical Characteristics And Economic Burden Of United States Veteran Patients Diagnosed With The Hepatitis C Virus

    Nov 1, 2016, 00:00

  • Access To New Drugs After The Introduction Of The 2011 Reimbursement Act In Poland

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Alternative Treatment Options for Colorectal Cancer in Greece

    Nov 1, 2016, 00:00

  • Efficacy of The Fixed Combination of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Vs Traditional Topical Treatment In Psoriasis- A Bayesian Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Analysis Of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2015 In Spain

    Nov 1, 2016, 00:00

  • Economic Burden Of Primary Immunodeficiency In National Institute Of Pediatrics In Mexico

    Nov 1, 2016, 00:00

  • Changing Of Prescriptions For Diabetes, Hyperlipidemia, And Hypertension, From Generic Drugs To Protected Brand Drugs - A Retrospective Cohort Study Using A National Inpatient Database In Japan

    Nov 1, 2016, 00:00

  • Analysis Of Real Data For Treatment Of Nausea And Vomiting Of Pregnancy (Nvp) In Ukraine

    Nov 1, 2016, 00:00

  • A Conceptual Approach For Including Productivity Losses In Health Economic Evaluations From A Societal Viewpoint

    Nov 1, 2016, 00:00

  • Estimating the Economic Impact Due to Productivity Losses of Diabetes and Major Depressive Disorder in Singapore- Human Capital Versus Friction cost Approaches

    Nov 1, 2016, 00:00

  • Correctly Capturing Uncertainty in Treatment Effects in Simulation Modeling

    Nov 1, 2016, 00:00

  • Health Outcomes Assessment and Treatment Regimens For Patients with Gastric Cancer in Shanghai China

    Nov 1, 2016, 00:00

  • Factors Associated with the Use of Complementary Medicines in Hypertension

    Nov 1, 2016, 00:00

  • Comparative Analysis of Consumption of Antipsychotic Drugs For Treating Schizophrenia in Hospitals in Russian Federation

    Nov 1, 2016, 00:00

  • Study on Age-Related Drug Use Pattern and Assessment of Medication Adherence in Patients with Chronic Respiratory Diseases

    Nov 1, 2016, 00:00

  • Real-World Quality-Adjusted Life-Years Gains In Portuguese Patients with Rheumatoid Arthritis Following 1 Year of Golimumab Treatment

    Nov 1, 2016, 00:00

  • Factors Affecting Prolonged Length of Stay In Patents With Mood Disorders

    Nov 1, 2016, 00:00

  • Increase Hospital Physicians’ Awareness of Expenditure Generated by Their Prescription in the Ambulatory Sector- Learning from the Experience of the 37 Public Hospitals of Paris in Diabetology

    Nov 1, 2016, 00:00

  • A Secure Smartphone Application For Clinical Research On Wound Healing- Nurstrial

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities in Children with Asthma

    Nov 1, 2016, 00:00

  • Systematic Literature Review and Assessment of the Reporting Quality of Economic Evaluation Studies in Non-Small Cell Lung Cancer in China

    Nov 1, 2016, 00:00

  • The Effects Of Food Prices On Weight Outcomes. A Systematic Review Of The Moderating Effects Of Income And Initial BMI

    Nov 1, 2016, 00:00

  • The Evolution Of Patient Access Schemes

    Nov 1, 2016, 00:00

  • Translation of the UK Paediatric Influenza Primary School Vaccination Programme to 13 European Countries Using a Dynamic Transmission Model

    Nov 1, 2016, 00:00

  • Barriers Influencing Implementation of Guidelines Into Clinical Practice in Czech Republic

    Nov 1, 2016, 00:00

  • Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal Cancer

    Nov 1, 2016, 00:00

  • Evaluation of the Direct Costs of Health Care During the First Year of Life of Babies Born with Microcephaly in the SUS

    Nov 1, 2016, 00:00

  • Perception Survey on Health Technology Assessment in Turkey- Does Practice Meet with Regulations

    Nov 1, 2016, 00:00

  • Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis In Europe

    Nov 1, 2016, 00:00

  • The Effects of Pay for Response and Maximum Price CAP Schemes on Payer and Provider Risk

    Nov 1, 2016, 00:00

  • Budget Impact of Secukinumab For Ankylosing Spondylitis In The UK

    Nov 1, 2016, 00:00

  • Disease Modifying Treatment (Dmt) is Associated with Lower Hazard for Death Among Multiple Sclerosis (Ms) Patients- Survival Analysis Based on 30 Years Incident Ms Cohort

    Nov 1, 2016, 00:00

  • The Economic Burden of Schizophrenia in Malaysia

    Nov 1, 2016, 00:00

  • Prescription Data in Australia- How Useful is this ‘Big' Data?

    Nov 1, 2016, 00:00

  • Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

    Nov 1, 2016, 00:00

  • The Value Of Patient Reported Outcomes In German Amnog Dossiers

    Nov 1, 2016, 00:00

  • Differentiation Of Health Related Quality Of Life Outcomes Between Patient Populations; Results From Patients With Breast Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Rare Cancers And Rare Diseases

    Nov 1, 2016, 00:00

  • A Meta Regression Analysis of Utility Weights for Breast Cancer

    Nov 1, 2016, 00:00

  • Pivotal Studies of Oncology Drugs Approved in Europe, Which Evidence Based-Medicine?

    Nov 1, 2016, 00:00

  • The Study of the Effect of Pharmacy Manager's Managerial Skills on the Performance of Community Pharmacies of Tehran

    Nov 1, 2016, 00:00

  • The Cost Of Multiple Sclerosis In 16 European Countries- Functional Status, Symptoms And Mental Factors Drive Costs

    Nov 1, 2016, 00:00

  • Prevalence of Severe Asthma and Poorly Controlled Severe Asthma During 2009–2013 in The Netherlands

    Nov 1, 2016, 00:00

  • Rapid Health Technology Assessment – Valveless Trocar System for Advanced Laparoscopic / Robotic Surgery

    Nov 1, 2016, 00:00

  • Financial Analysis of the Final Prices, Co-Paymants and Reimbursment of Antihypertensives in Slovakia from 2008-2014

    Nov 1, 2016, 00:00

  • Diffusion of Trans-Arterial Radioembolization for The Treatment of Intermediate-Advanced Hepatocellular Carcinoma in Italy- A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Retrospective Review of Observational Data Requested by the French Health and Technology Assessment Agency- How are Results Taken Into Account?

    Nov 1, 2016, 00:00

  • To Evaluate the Outcomes of Concomitant Chemoradiotherapy Followed by Extended Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma - A Retrospective Study

    Nov 1, 2016, 00:00

  • Combination Oncologics- A Boon or Burden to Healthcare Systems?

    Nov 1, 2016, 00:00

  • Impact of Adoption of A New Drug on the Trends in Utilization Patterns Changes and Pharmaceutical Expenditure- An Example of Urate-Lowering Therapy

    Nov 1, 2016, 00:00

  • Development Of Day Surgery In Hungary Between 2004-2014

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Pegylated Liposomal Doxorubicin Versus Doxorubicin In Patients with Metastatic Breast Cancer at High Risk of Cardiac Events

    Nov 1, 2016, 00:00

  • The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability- Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours

    Nov 1, 2016, 00:00

  • The Pareto Principle ("80−20 Rule") In Healthcare Services In Greece

    Nov 1, 2016, 00:00

  • Economic Analysis of Scaling Up Access to Modern Family Planning Methods in Low and Middle-Income Countries; Case Studies for Indonesia and Uganda

    Nov 1, 2016, 00:00

  • Market Access Challenges of Drugs for Chronic Hepatitis C- A Thematic Analysis of Health Technology Assessments

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Obinutuzumab And Ibrutinib In Patients With Chronic Lymphocytic Leukemia In Russia

    Nov 1, 2016, 00:00

  • The Impact of Atrial Fibrillation on the Economic Burden of Ischemic Stroke Patients in Beijing

    Nov 1, 2016, 00:00

  • Annual Cost of Illness of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) in Turkey

    Nov 1, 2016, 00:00

  • The Impact of Haemophilia Complications on Health-Related Quality of Life for Adults with Severe Haemophilia

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Patients with Rheumatoid Arthritis At Uttaradit Hospital, Thailand

    Nov 1, 2016, 00:00

  • Cost-Effectivness Analysis of Axitinib In The Treatment of Metastatic Renal Cell Carcinoma – Clinical Data Vs RWE

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Regorafenib In Gastrointestinal Stromal Tumours In England Using Crossover Adjustment Methods

    Nov 1, 2016, 00:00

  • The Trends of Emergency Care Admissions Focusing on The Population Over 65 Years of Age

    Nov 1, 2016, 00:00

  • Mapping Transactions from Pharmaceutical Companies to Healthcare Organisations in the EU5

    Nov 1, 2016, 00:00

  • Self-Reported Sleep Quality, Duration And Health-Related Quality Of Life In Older Chinese

    Nov 1, 2016, 00:00

  • Adherence, Healthcare Resource Utilization and Direct Medical Costs Among Patients with Alzheimer's Disease in Tianjin, China

    Nov 1, 2016, 00:00

  • Thresholds for Clinical Importance in EORTC-QLQ-C30- Application in A Sample of Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece

    Nov 1, 2016, 00:00

  • Access to New Health Technologies in The Brazilian Health System- Disseminating Information to Law Operators for Qualifying The Health Decisions

    Nov 1, 2016, 00:00

  • Adaptive Prediction of Symptoms Return Upon Discontinuation of Omalizumab Treatment in Chronic Spontaneous Urticaria Patients

    Nov 1, 2016, 00:00

  • Influence of Medical–Economic Analysis on the Categorization of Special Medical Equipment

    Nov 1, 2016, 00:00

  • Bevacizumab in The Treatment of Kras Wild Type Metastatic Colorectal Cancer- An Economic Analysis Based on The Calgb 80405 Trial

    Nov 1, 2016, 00:00

  • A Framework For Measuring Adherence To Multiple Medications

    Nov 1, 2016, 00:00

  • Health Insurance-Related Aspects Of Home-Based Parenteral Nutrition In Hungary

    Nov 1, 2016, 00:00

  • Cost Comparison Of Medical And Surgical Treatments For Medically Intractable Epilepsy

    Nov 1, 2016, 00:00

  • A Case Study on the Development, Implementation and Outcome of Critical Disease Insurance in Shen Zhen, China

    Nov 1, 2016, 00:00

  • Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors Among Undergraduate Male Students In An Ethiopian University- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Switching Patterns from Warfarin to Non-Vitamin K Oral Anticoagulants In Ireland

    Nov 1, 2016, 00:00

  • The use of Alhijama as Complimentary Treatment in Hypertension

    Nov 1, 2016, 00:00

  • Review of the Recommendations Made by the National Institute for Health and Care Excellence (NICE) and the Scottish Medicial Consortium (SMC) Relating to Treatments for Rare Diseases

    Nov 1, 2016, 00:00

  • Real World Evidence in Europe- A Snapshot of its Current Status

    Nov 1, 2016, 00:00

  • The Medication Adherence in Schizophrenia Management by Using Second Generation Antipsychotics in Taiwan- A Population Study Based on Nhrid

    Nov 1, 2016, 00:00

  • Market Regulation May Influence Drug Price Trajectories - A Comparison of Anti Tumor Necrosis Factor Drug Prices In Israel And The USA

    Nov 1, 2016, 00:00

  • Clinical Outcome and Health Care Costs of Blood Stream Infections with Resistant Klebsiella Pneumoniae in Pediatric Patients

    Nov 1, 2016, 00:00

  • Can We Predict Adherence in Diabetes Patients Based on Medication Characteristics?

    Nov 1, 2016, 00:00

  • The Prevalence Of Sexual Dysfunctions Among Hungarian Men

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • Comparison of Economic Evaluation Guidelines Between Japan and other Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of On-Pump and Off-Pump Stable Multivessel Coronary Artery Bypass Grafting–mass iii 5-Year Follow-Up

    Nov 1, 2016, 00:00

  • Prevalence and Management of Anemia in Patients of Chronic Kidney Disease at a Tertiary Care Public Teaching Hospital- Evidence from a Cross Sectional Study

    Nov 1, 2016, 00:00

  • Assessment Of Prices Of Essential Medicines For Chronic Diseases Prevalent In The Asia Pacific Region

    Nov 1, 2016, 00:00

  • Ethical and Technological Evaluation of Security of Connected Objects and Health Applications- How to Move Towards Certification

    Nov 1, 2016, 00:00

  • The Utilization of Health Services By The Older Europeans- An Econometric Analysis

    Nov 1, 2016, 00:00

  • Cardiovascular Diseases- Pharmacotherapy Utilization In Western Europe and CEE

    Nov 1, 2016, 00:00

  • Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language Processing

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Introducing Pharmacist-Managed Warfarin Service In The Republic of Serbia

    Nov 1, 2016, 00:00

  • The Declining Value of Economics in Canadian Cancer Reimbursement Reviews

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Initial IV Antibiotics for Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Drug Utilization in an Outpatient Private Paediatric Setting- An Observational Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution And Tobramycin Dry Powder For Inhalation In Cystic Fibrosis Patients In Sweden

    Nov 1, 2016, 00:00

  • Burden of Visual Impairment Due to Myopic Choroidal Neovascularisation (MCNV) in Turkey

    Nov 1, 2016, 00:00

  • Cost Patterns in Patients Treated with Spinal Cord Stimulation Following Spine Surgery—A Register Based Study

    Nov 1, 2016, 00:00

  • Incidence Cancer Costs Associated with Head And Neck (HN) Cancers- A Nationwide Study From France In 2008-2013 (EPICORL STUDY)

    Nov 1, 2016, 00:00

  • Non-Parametric Approach to Estimating Expected Value of Perfect Information- The Usefulness of this Approach to a National HTA Agency

    Nov 1, 2016, 00:00

  • A Prospective Assessment of Attitudes and Experiences Among Urologists Regarding off Label Use of BCG Vaccine in Serbia

    Nov 1, 2016, 00:00

  • DPP-4 Inhibitors and Cardiovascular Events in Type 2 Diabetic Patients with Chronic Kidney Disease -- A Nationwide Cohort Study

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of The Introduction of Generic Bosentan For The Treatment of Pulmonary Arterial Hypertension In Greece

    Nov 1, 2016, 00:00

  • Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Colorectal Cancer Screening in Austria and Assessment of The Impact of Cancer-Causing Risk Factors

    Nov 1, 2016, 00:00

  • Important Methodological Considerations and Strategies for Resolution for Multinational Retrospective Chart Review Studies

    Nov 1, 2016, 00:00

  • Supplementing the Right Way- Effective Cost Management of Multivitamin Syrups in a Paediatric Hospital

    Nov 1, 2016, 00:00

  • Antiviral Activity and Embryonic Toxicity of Moxidectin Against Influenza Virus H9

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis for Direct Visual Observation of Nasogastric Enteral Feeding Tube Placement

    Nov 1, 2016, 00:00

  • Effective Use of Short-Term Healthcare By Immigrants In Chile- Linking Evidence To Policy For Universal Coverage

    Nov 1, 2016, 00:00

  • Capacity for Endoscopic Screening for Gastric Cancer in Japan

    Nov 1, 2016, 00:00

  • Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study

    Nov 1, 2016, 00:00

  • HBSAG Seroclearance after Treatment-Induced HBEAG Seroclearance in Chronic Hepatitis B Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Tasks Involved In Platelet Production And Transfusion From The U.S. Hospital Perspective- Two Process Frameworks

    Nov 1, 2016, 00:00

  • Cyproterone/Ethinylestradiol and Concomitant Use of other Hormonal Contraceptives in the Netherlands

    Nov 1, 2016, 00:00

  • Reform of Chinese State-Owned Enterprise-Affiliated Hospital

    Nov 1, 2016, 00:00

  • Impact of The International Reference Pricing on Access To Standard Therapy Drugs for Asthma and Copd

    Nov 1, 2016, 00:00

  • Cost Per Responder of Lixisenatide Versus Rapid-Acting Insulin Intensification Regimens in an Insulin-Exposed Type 2 Diabetes Mellitus (T2DM) Population

    Nov 1, 2016, 00:00

  • Clinical And Economic Outcomes Of Pharmacist Intervention During Therapeutic Drug Monitoring Program In Saudi Arabia

    Nov 1, 2016, 00:00

  • Real World Anaplastic Lymphoma Kinase (ALK) Rearrangement Testing Patterns, Treatment Sequences and Survival of ALK-Inhibitor Treated Patients

    Nov 1, 2016, 00:00

  • Health State Utilities for Persistent, Recurrent or Metastatic Cervical Cancer in France

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of Health Care Workers Perceptions and Attitude on Pharmacists Involvement in Ward Round in Three Tertiary Hospitals in South-East Nigeria

    Nov 1, 2016, 00:00

  • Health State Utilities Associated with Post-Surgical Staphylococcus Aureus Infection

    Nov 1, 2016, 00:00

  • Bilirubin and Neurodegenerative Disease Prevention

    Nov 1, 2016, 00:00

  • Guidelines for Translation and Cross-Cultural Adaptation of Non-Technical Skills Rating Instruments

    Nov 1, 2016, 00:00

  • Comparing Preferences Of Patients With Rheumatic Diseases, Of Experienced Rheumatologists, Nurses And Pharmacists Toward The Treatment Of Rheumatic Diseases With Biological Agents- Results From The Cara Study

    Nov 1, 2016, 00:00

  • What's New in the Guidelines for Submission of Dossier for Listing into the Ministry of Health Medicines Formulary (Mohmf) ?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rituximab in the Treatment of Diffuse Large B-Cell Non-Hodgkin's Lyphoma Patients (Dlbcl) in China

    Nov 1, 2016, 00:00

  • Evaluating Socio-Demographic Characteristics Of Patients In The United States Department Of Defense Population

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Therapy To Prevent Osteoporotic Fractures In Postmenopausal Women With Osteopenia

    Nov 1, 2016, 00:00

  • Resource Use In Idiopathic Pulmonary Fibrosis- Influence of Disease Progression and Exacerbations

    Nov 1, 2016, 00:00

  • Variations in Stakeholder Preferences between Innovative Pricing Agreement Types Across the EU5

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec Treatment in Patients with Type1 and Type 2 Diabetes Mellitus- A Systematic Review

    Nov 1, 2016, 00:00

  • 19th Euro - FDS Financial Disclosure Statements

    Nov 1, 2016, 00:00

  • A Systematic Review of The SF-36® Health Survey for Measuring Health-Related Quality of Life In Patients with Ulcerative Colitis

    Nov 1, 2016, 00:00

  • TBO-Filgrastim Patterns of Care by Treatment Site and Setting in The United States, 2014 and 2015

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Latin America

    Nov 1, 2016, 00:00

  • Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil

    Nov 1, 2016, 00:00

  • Comparison of Methods to Assess the Relative Importance of Criteria in Multi-Criteria Decision Analysis- An Evaluation of Orphan Drugs in Russia

    Nov 1, 2016, 00:00

  • Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Cost-Minimisation Analysis of Sucroferric Oxhydroxide and Sevelamer Carbonate in Patients on Dialysis with Secondary Hyperparathyroidism in Six European Countries

    Nov 1, 2016, 00:00

  • High Levels Of Fears Of Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis Are Associated With Gender, Disease Activity, Anxiety And Depression- A Cross-Sectional Study Of 672 Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of D-Dimer in The Diagnosis of Venous Thromboembolism in Colombia

    Nov 1, 2016, 00:00

  • How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?

    Nov 1, 2016, 00:00

  • The Longterm Cost Effectiveness of the “Coaching Patients on Achieving Cardiovascular Health” (Coach) Program in Type 2 Diabetes in Tasmania

    Nov 1, 2016, 00:00

  • Safety Profile of Daclizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2016, 00:00

  • Costs of HPV-Related Cancers in The Netherlands

    Nov 1, 2016, 00:00

  • Missing the Value of Herd Immunity in Cost-Effectiveness Analysis. A Systematic Review

    Nov 1, 2016, 00:00

  • Health Economics Analyses for Medical Devices in Asia- A Literature Review

    Nov 1, 2016, 00:00

  • GLP-1 Receptor Agonist Treatment-Related Features Important to Type 2 Diabetes Mellitus (T2DM) Patients- A Preference Study in Germany

    Nov 1, 2016, 00:00

  • Estimating The Impact Associated To The Use Omalizumab In The Treatment of Severe Persistent Allergic Asthma In Portugal – Evaluating Outcomes And Treatment Costs Using Real World Data From Portuguese Patients

    Nov 1, 2016, 00:00

  • Analysis of Antibiotics’ Use in the Treatment of Tonsillopharyngitis in Children Population of Nis District

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of National Screening Program for Pulmonary Tuberculosis in Korea

    Nov 1, 2016, 00:00

  • Course of Therapy, Resource Utilization and Costs for The Treatment of Metastatic Colorectal Cancer in Germany

    Nov 1, 2016, 00:00

  • Measuring The Influence Of Patient Counseling At Tertiary Care Hospital In Antenatal Care, South Karnataka, India

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Active Surveillance of Beta-D-Glucan in Intensive Care Units in Hong Kong

    Nov 1, 2016, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments in Moderate to Severe Psoriasis is Associated with Incremental Pharmacy Costs- A Real-World Study in the UK

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Utility Scores in Leukemias

    Nov 1, 2016, 00:00

  • Association between Copayment, Medication Adherence and Outcomes in the Management of Patients with Diabetes and Heart Failure

    Nov 1, 2016, 00:00

  • The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool- Which Implications for Value Assessment of Cancer Therapies?

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation Associated with Patients Treated with Either Exenatide Once Weekly or Basal Insulin- A Retrospective UK Database Analysis

    Nov 1, 2016, 00:00

  • Burden of Low Vision and Blindness in Chinese Elder Popullation-Data from Field Survey

    Nov 1, 2016, 00:00

  • The Increasing Importance of A Continence Nurse Specialist To Improve Outcomes And Save Costs of Urinary Incontinence Care- An Analysis of Future Policy Scenarios

    Nov 1, 2016, 00:00

  • Decision Uncertainty and Need for Further Research- A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

    Nov 1, 2016, 00:00

  • Effect Of A Multifactorial, Interdisciplinary Intervention On Falls And Fall Rate Of The Older People In The Community

    Nov 1, 2016, 00:00

  • Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia

    Nov 1, 2016, 00:00

  • Eltrombopag Vs Romiplostim In Adult Patients With Chronic Immune Trombocytopenia- Economic Evaluation

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

    Nov 1, 2016, 00:00

  • Parametric and Non-Parametric Approaches for Predicting Bacterial Resistance

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Asia-Pacific (APAC) Markets- Systematic Evaluation in 10 APAC Countries

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis of Dental Prosthesis in Ukraine

    Nov 1, 2016, 00:00

  • Assessment of Adhesion Response To 3D Printed Materials For Ophthalmic Device Development

    Nov 1, 2016, 00:00

  • Drug Use Analysis of Patients with Hypertension and Diabetes in Shanghai, China- Based on Drug Bidding Database of Shanghai Medical Instituions

    Nov 1, 2016, 00:00

  • Future Disparities Between Demand And Supply of Tertiary Emergency Care In Regions Affected By The Great East Japan Earthquake

    Nov 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts For Pharmaceutical Innovations In Germany When Price Negations Between Payors And Manufacturers Fail- An Empirical Analysis Of 5 Years' Experience

    Nov 1, 2016, 00:00

  • How much do the insured citizens know about the personal account of china's urban employees' basic medical insurance and what are their needs? Evidence from guizhou, china

    Nov 1, 2016, 00:00

  • Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design- An Example in A Rare Cardiac Clinical Trial

    Nov 1, 2016, 00:00

  • Patient Perspectives on Merkel Cell Carcinoma (MCC) and Its Treatment with A Novel Agent (AVELUMAB)- Findings From In-Depth Qualitative Patient Interviews

    Nov 1, 2016, 00:00

  • The Choice of A Fluoropyrimidine Regimen in Patients with Advanced Colorectal Cancer

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv)- A Systematic Literature Review (Slr) Using Rapid Review Methodology

    Nov 1, 2016, 00:00

  • An Indirect Comparison Between Adalimumab, Baricitinib And Tofacitinib For The Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Comparison Between Eq-5d And Hui In Japanese Population Norms

    Nov 1, 2016, 00:00

  • Patient Information And Consent Form In Europe- Requirements From Regulatory Authorities For Pharmaco-Epidemiological Studies

    Nov 1, 2016, 00:00

  • The Burden of Severe Asthma in France

    Nov 1, 2016, 00:00

  • The Prescribing, Inpatient, Outpatient and Social Care Costs Associated with Atrial Fibrillation in Scotland- A Record Linkage Study

    Nov 1, 2016, 00:00

  • A Comparison of Insulin Degludec Clinical Evaluations and Recommendations Between an Independent HTA and National HTA Bodies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In Portugal

    Nov 1, 2016, 00:00

  • Health Related Quality of Life In The Deaf British Signing Population

    Nov 1, 2016, 00:00

  • Stroke Treatment Cost Analysis for Consideration on Health Cost Determination Using INA-CBG'S (Indonesia Case Based Groups) in Indonesia National Health Insurance Programme 2014

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75 (current)
  • 76
  • 77
  • 78
  • 79
  • 80
  • »